Summary: TRPV1 and SHANK3 could play a role in pain insensitivity in people with autism, a new study reports.
Source: Duke University.
Well-known autism and pain proteins are likely co-conspirators.
Sensory problems are common to autism spectrum disorders. Some individuals with autism may injure themselves repetitively — for example, pulling their hair or banging their heads — because they’re less sensitive to pain than other people.
New research points to a potential mechanism underlying pain insensitivity in autism. The study, conducted by two teams at Duke University and appearing online Dec. 1 in the journal Neuron, is the first to connect autism to one of the most well-studied pain molecules, called TRPV1 (transient receptor potential ion channel subtype V1), which is a receptor for the main spicy component of chili peppers.
“Not enough research has been done on the mechanisms driving sensory problems in autism, but it’s important because sensory processing probably affects to some degree how the brain develops,” said co-author Yong-hui Jiang, M.D., Ph.D., associate professor of pediatrics and neurobiology at Duke. Jiang collaborated with Ru-Rong Ji, Ph.D., professor of anesthesiology and neurobiology and chief of pain research in Duke University School of Medicine’s Department of Anesthesiology.
In a study published earlier this year, Jiang and other collaborators at Duke described a mouse model of autism in which they deleted a prominent autism gene called SHANK3, which is mutated in 1 percent of people with the disorder. These mice show several features of autism, including social deficits and excessive self-grooming.
That study did not examine pain. But about 70 percent of individuals with autism or a related disorder called Phelan-McDermid syndrome who have mutations in SHANK3 are known to have sensory processing problems, according to Jiang, who treats children with autism at Duke’s Children Hospital & Health Center.
In the new study, Ji’s group put SHANK3-deficient mice through a battery of sensory tests, finding that the animals had lower sensitivity than normal mice to heat and heat-related pain — akin to the soreness a person feels after a sunburn.
It turns out that the SHANK3 protein is normally present not only in the brain, but also in a cluster of pain-sensing neurons called the dorsal root ganglion in mice. The group also found SHANK3 in the same types of cells from human donors who did not have autism.
“This was a big surprise that SHANK3 is expressed in the peripheral nervous system, but before this study, no one had ever looked for it outside of the brain,” Ji said.
The scientists found that TRPV1 and SHANK3 are actually present together in sensory neurons of the dorsal root ganglion, and that they interact. In the mice missing SHANK3, TRPV1 never makes it to the cell surface, where it normally does its job. Missing even half of normal level of SHANK3 drastically lowers TRPV1’s ability to transmit pain signals, suggesting that SHANK3 is a crucial molecule for pain sensation.
SHANK3 is better known for its role in the brain. It is found in the tiny clefts called synapses where signals are passed from one neuron to the next. Until now, it was believed to be present only in the receiving end of the synapse, called the postsynaptic terminal, where it acts as a scaffold to secure specific receptors that receive chemical messages.
The new study also shows that SHANK3 is expressed on the sending sides of the synapse, called presynaptic terminals. The scientists hope to understand next what the protein might be doing there.
“That changes our understanding of how these two components (of the synapse) work together to contribute to autism-related behavior and will change how we develop effective treatments,” Jiang said.
TRPV1 blockers are already the focus of intense research and development, but these compounds come with side effects. The new study suggests a more specific way to block TRPV1 — through its interaction with SHANK3 — in order to avoid these side effects, Ji said.
Ji and Jiang are both members of the Duke Institute for Brain Sciences. The study also includes three co-first authors: Qingjian Han from Ji’s group who discovered SHANK3 in sensory neurons and pain defects in SHANK3 mutant mice; Yong Ho Kim, an electrophysiologist in Ji’s group who found diminished TRPV1 function in SHANK3 mutant mice; and Xiaoming Wang from Jiang’s lab who generated SHANK3 mutant mice.
Funding: This research was supported by the National Institutes of Health (R01 NS87988, R01 DE17794, R01 DE22743, R01 MH098114, R21 HD077197, and R21 MH1043136) and the Phelan-McDermid Syndrome Foundation.
Source: Karl Bates – Duke University
Image Source: NeuroscienceNews.com image is credited to Qingjian Han, Duke University School of Medicine.
Original Research: Abstract for “SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons” by Qingjian Han, Yong Ho Kim, Xiaoming Wang, Di Liu, Zhi-Jun Zhang, Alexandra L. Bey, Mark Lay, Wonseok Chang, Temugin Berta, Yan Zhang, Yong-Hui Jiang, nd Ru-Rong Ji in Neuron. Published online December 1 2016 doi:10.1016/j.neuron.2016.11.007
SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons
•SHANK3 is expressed in primary sensory neurons and spinal cord central terminals
•Shank3 haploinsufficiency in sensory neurons leads to impaired heat hyperalgesia
•SHANK3 in mouse and human DRG neurons regulates TRPV1 function
•SHANK3 interacts with TRPV1 and modulates presynaptic pain transmission
Abnormal pain sensitivity is commonly associated with autism spectrum disorders (ASDs) and affects the life quality of ASD individuals. SHANK3 deficiency was implicated in ASD and pain dysregulation. Here, we report functional expression of SHANK3 in mouse dorsal root ganglion (DRG) sensory neurons and spinal cord presynaptic terminals. Homozygous and heterozygous Shank3 complete knockout (Δe4–22) results in impaired heat hyperalgesia in inflammatory and neuropathic pain. Specific deletion of Shank3 in Nav1.8-expressing sensory neurons also impairs heat hyperalgesia in homozygous and heterozygous mice. SHANK3 interacts with transient receptor potential subtype V1 (TRPV1) via Proline-rich region and regulates TRPV1 surface expression. Furthermore, capsaicin-induced spontaneous pain, inward currents in DRG neurons, and synaptic currents in spinal cord neurons are all reduced after Shank3 haploinsufficiency. Finally, partial knockdown of SHANK3 expression in human DRG neurons abrogates TRPV1 function. Our findings reveal a peripheral mechanism of SHANK3, which may underlie pain deficits in SHANK3-related ASDs.
“SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons” by Qingjian Han, Yong Ho Kim, Xiaoming Wang, Di Liu, Zhi-Jun Zhang, Alexandra L. Bey, Mark Lay, Wonseok Chang, Temugin Berta, Yan Zhang, Yong-Hui Jiang, nd Ru-Rong Ji in Neuron. Published online December 1 2016 doi:10.1016/j.neuron.2016.11.007